CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 68 enrolled
Drug / intervention
Elix Cycle Balancedietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05145257
NCT05145257N/ACompleted

Study to Evaluate the Efficacy of Elix's Cycle Balance and Its Impact on PMS and Menstrual Symptoms

Zenchi, Inc.·interventional·Posted Dec 6, 2021·Updated Jan 1, 2025

In Brief

A clinical study evaluating Elix Cycle Balance for PMS and Menstrual Pain. Completed, enrolled 68 participants across 1 site.

Detailed Summary

This is an open-label observational single-group clinical trial to study the efficacy of a commercially available dietary supplement and its effect on common PMS and menstrual symptoms. It is hypothesized that the dietary supplement marketed as "Elix Cycle Balance" will improve subjective wellbeing in trial participants by alleviating common symptoms of PMS and menstrual symptoms, such as cramps, bloating, and mood swings. A total of 65 participants will be recruited for the trial following screening, with the expectation that at least 50 participants will complete the trial. The trial will be fully remote, a technology platform will be utilized to screen, enroll and capture study data of the participants. The total intervention study period will be 3 months.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPMS, Menstrual Pain
CountriesUnited States
CollaboratorsCitruslabs

Timeline

N/ACompletedFinished
20222023202420252026
First PostedDec 6, 2021
Enrollment StartJan 5, 2022
Primary CompletionMay 31, 2022
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 4.6 years ago

Interventions

Elix Cycle Balancedietary

Each day in the morning and at night in the week prior to the menstruation, the participants will take 6 full droppers of Elix Cycle Balance